Ann Thor

895 total citations
9 papers, 750 citations indexed

About

Ann Thor is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ann Thor has authored 9 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Ann Thor's work include Cancer-related Molecular Pathways (3 papers), Cell death mechanisms and regulation (2 papers) and Cell Adhesion Molecules Research (2 papers). Ann Thor is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Cell death mechanisms and regulation (2 papers) and Cell Adhesion Molecules Research (2 papers). Ann Thor collaborates with scholars based in United States and Italy. Ann Thor's co-authors include Britt‐Marie Ljung, Helene S. Smith, Christopher C. Benz, Maurice Barcos, Mei He, Marc A. Shuman, Elisabetta Bianchi, Austin L. Vickery, J. Larry Jameson and Helen Karga and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Cancer and International Journal of Oncology.

In The Last Decade

Ann Thor

9 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Thor United States 9 409 311 293 128 119 9 750
J.J.T.M. Heuvel Netherlands 16 401 1.0× 444 1.4× 399 1.4× 38 0.3× 105 0.9× 22 886
Ulrike Lacher Germany 10 295 0.7× 284 0.9× 631 2.2× 28 0.2× 59 0.5× 14 942
Christina V. Obiezu Canada 14 285 0.7× 122 0.4× 303 1.0× 65 0.5× 108 0.9× 16 1.0k
Lisa E. Humphrey United States 17 442 1.1× 112 0.4× 498 1.7× 65 0.5× 35 0.3× 23 783
Craig Cadwell United States 10 384 0.9× 348 1.1× 582 2.0× 78 0.6× 93 0.8× 14 1.0k
Henry Koo United States 5 237 0.6× 186 0.6× 538 1.8× 216 1.7× 34 0.3× 6 731
Vanessa Cerisano Italy 11 183 0.4× 163 0.5× 396 1.4× 137 1.1× 37 0.3× 11 750
Anna Dowe United Kingdom 13 245 0.6× 264 0.8× 537 1.8× 105 0.8× 189 1.6× 15 951
Andrew Berchuck United States 10 375 0.9× 203 0.7× 560 1.9× 23 0.2× 149 1.3× 11 1.1k
G Merlo Italy 12 590 1.4× 230 0.7× 516 1.8× 31 0.2× 94 0.8× 13 856

Countries citing papers authored by Ann Thor

Since Specialization
Citations

This map shows the geographic impact of Ann Thor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Thor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Thor more than expected).

Fields of papers citing papers by Ann Thor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Thor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Thor. The network helps show where Ann Thor may publish in the future.

Co-authorship network of co-authors of Ann Thor

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Thor. A scholar is included among the top collaborators of Ann Thor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Thor. Ann Thor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Yang, Shihe, Joan Liu, Ann Thor, & Xiaohe Yang. (2007). Caspase expression profile and functional activity in a panel of breast cancer cell lines. Oncology Reports. 17(5). 1229–35. 18 indexed citations
2.
Yang, Xiao, Susan M. Edgerton, & Ann Thor. (2005). Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy. International Journal of Oncology. 26(6). 1675–80. 33 indexed citations
3.
Bianchi, Elisabetta, Robert L. Cohen, Aihua Dai, et al.. (1995). Immunohistochemical localization of the plasminogen activator inhibitor‐1 in breast cancer. International Journal of Cancer. 60(5). 597–603. 56 indexed citations
4.
Bianchi, Elisabetta, Roger Cohen, Ann Thor, et al.. (1994). The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue.. PubMed. 54(4). 861–6. 139 indexed citations
5.
Deng, Guoren, Ann Thor, Vivek Bhargava, et al.. (1994). Loss of heterozygosity and p53 gene mutations in breast cancer.. PubMed. 54(2). 499–505. 104 indexed citations
6.
Thor, Ann, et al.. (1992). The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast.. PubMed. 7(5). 1027–32. 161 indexed citations
7.
Karga, Helen, Jenn‐Kuen Lee, Austin L. Vickery, et al.. (1991). RasOncogene Mutations in Benign and Malignant Thyroid Neoplasms. The Journal of Clinical Endocrinology & Metabolism. 73(4). 832–836. 139 indexed citations
8.
Jagirdar, Jaishree, et al.. (1989). ras oncogene p21 expression in hepatocellular carcinoma.. PubMed. 4(1). 37–46. 12 indexed citations
9.
Thor, Ann, Noriaki Ohuchi, Robert Callahan, et al.. (1986). ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues.. PubMed. 55(6). 603–15. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026